Provided by Tiger Trade Technology Pte. Ltd.

Tredegar

7.16
-0.2400-3.24%
Post-market: 7.160.00000.00%19:30 EDT
Volume:126.08K
Turnover:907.77K
Market Cap:249.96M
PE:7.48
High:7.49
Open:7.48
Low:7.13
Close:7.40
52wk High:10.53
52wk Low:6.25
Shares:34.91M
Float Shares:28.20M
Volume Ratio:1.20
T/O Rate:0.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9572
EPS(LYR):0.9604
ROE:15.47%
ROA:6.50%
PB:1.09
PE(LYR):7.46

Loading ...

TG Therapeutics: Buy Rating Reiterated on Briumvi Expansion Strategy, $70 Price Target Unchanged

TIPRANKS
·
Jun 09

Major Insider Trio Quietly Trims Tredegar Holdings in Synchronized Stock Moves

TIPRANKS
·
Jun 09

Tredegar 10% owner James T. Gottwald disposes of 3,367 common shares worth $26,668.08

Reuters
·
Jun 09

Tredegar 10% owner James T. Gottwald sells 1,044 shares for $8,184.19

Reuters
·
Jun 05

Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), TG Therapeutics (TGTX) and Dexcom (DXCM)

TIPRANKS
·
Jun 04

B. Riley Securities Remains a Buy on TG Therapeutics (TGTX)

TIPRANKS
·
Jun 04

TG Therapeutics rises 10.6%

TIPRANKS
·
Jun 04

Analysts’ Top Healthcare Picks: TG Therapeutics (TGTX), AbbVie (ABBV)

TIPRANKS
·
Jun 03

TG Therapeutics Reports Positive Phase 1 Data for Subcutaneous Multiple Sclerosis Therapy

MT Newswires Live
·
Jun 03

TG Therapeutics announces results from Briumvi trial

TIPRANKS
·
Jun 03

TG Therapeutics reports positive data for subcutaneous BRIUMVI

TIPRANKS
·
Jun 03

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

GlobeNewswire
·
Jun 03

TG Jones owner Modella puts jobs at risk in shoe retailer overhaul

cityam
·
Jun 02

Bonnell Aluminum names Carl Czarnik senior vice president, general manager

Reuters
·
Jun 02

Tredegar Announces Bonnell Aluminum Leadership Changes

THOMSON REUTERS
·
Jun 02

Tredegar 10% owner William M. Gottwald sells common shares worth $33,672

Reuters
·
Jun 02

Tredegar files Form 3 for Susan E. Sweeney, vice president and chief human resources officer

Reuters
·
Jun 01

Tredegar files Form 3 naming Joseph E. Haniford as director beneficial owner

Reuters
·
Jun 01

TG Therapeutics Announces Publication of Post-Hoc Data from the Phase 3 ULTIMATE I & II Trials in Treatment Naive Patients with Relapsing Forms of MS Published in Frontiers in Immunology

GlobeNewswire
·
Jun 01

TG Metals Advances Lake Johnston Lithium Project with Burmeister Mining Lease Application

TIPRANKS
·
Jun 01